Treatment with sumatriptan 50 mg in the mild phase of migraine attacks in patients with infrequent attacks. A randomized, double-blind, placebo-controlled study

Per Tfelt-Hansen, Flemming W. Bach, Dorte Daugaard, Ioannis Tsiropoulos, Birthe Riddersholm

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

OriginalsprogEngelsk
TidsskriftJournal of Headache and Pain
Vol/bind7
Udgave nummer6
Sider (fra-til)389-394
ISSN1129-2369
StatusUdgivet - 2006

Citationsformater